Tag: New York City

New York City, NY, July 11, 2025 (GLOBE NEWSWIRE) -- Short-term lending solutions remain a commonly used resource in this era's financial environment for consumers facing unforeseen costs. Borrowers with poor credit access remain especially reliant on payday loans when other avenues are not available. AnyDayCash, an online loan connection agency, brokers access to $1000 payday loans from a network of alternative lenders.

New York City, NY, July 11, 2025 (GLOBE NEWSWIRE) --  CrazyBulk, a leading provider of legal steroid alternatives, is excited to announce its expanded line of top-rated, natural supplements designed to help athletes and fitness enthusiasts build muscle, enhance strength, and lose fat. These cutting-edge products are formulated to provide safe, effective results, mimicking the effects of anabolic steroids without the associated side effects and legal risks.

New York City, July 10, 2025 (GLOBE NEWSWIRE) -- Ripple has established a partnership with the oldest bank on Wall Street, and BNY Mellon has become the custodian of RLUSD, which will take Ripple's stablecoin strategy to the next level and herald its long-term commitment to infrastructure construction. With the announcement of this strategic cooperation, the price of XRP soared rapidly, breaking through $2.46 at one point, and its market value jumped to the third largest cryptocurrency in the world.

New York City, NY, July 10, 2025 (GLOBE NEWSWIRE) -- Let’s face it — these days, being offline isn’t just inconvenient. It’s borderline disabling.

Staten Island, NY, July 09, 2025 (GLOBE NEWSWIRE) -- PureVoltage Hosting, a premier provider of high-performance infrastructure and enterprise-grade hosting solutions, is proud to announce a major expansion of its presence at the Telehouse facility located at 7 Teleport Drive in Staten Island, New York. This move continues to solidify PureVoltage as the largest client operating at 7 Teleport and marks a continued commitment to delivering scalable, resilient, and cutting-edge infrastructure services to customers worldwide. 

Daix (France), New York City (New York, United States), July 9, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic dysfunction-associated steatohepatitis (“MASH”), today announced a leadership transition with the appointment of Jason Campagna, MD, PhD, as President of Research and Development (“R&D”) and Chief Medical Officer (“CMO”) and Martine Zimmermann, PharmD, as Executive Vice President (“EVP”) of Regulatory Affairs and Quality Assurance.

Daix (France), New York City (New York, États-Unis), le 9 juillet 2025 – Inventiva (Euronext Paris et Nasdaq : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement de thérapies orales pour le traitement de la stéatohépatite associée à un dysfonctionnement métabolique (« MASH »), a annoncé aujourd'hui une transition au sein de son équipe de direction avec la nomination de Jason Campagna, MD, PhD, en tant que Président de la Recherche et du Développement (« R&D ») et Directeur Médical (« CMO »), ainsi que Martine Zimmermann, PharmD, en tant que Vice-Présidente Exécutive (« EVP ») en charge des affaires réglementaires et de l’ assurance qualité.